A detailed history of Franklin Resources Inc transactions in Takeda Pharmaceutical CO LTD stock. As of the latest transaction made, Franklin Resources Inc holds 17,028 shares of TAK stock, worth $225,791. This represents 0.0% of its overall portfolio holdings.

Number of Shares
17,028
Previous 17,028 -0.0%
Holding current value
$225,791
Previous $241,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$13.0 - $15.08 $221,364 - $256,782
17,028 New
17,028 $241,000
Q1 2024

May 13, 2024

BUY
$13.89 - $15.04 $792,007 - $857,580
57,020 Added 44.36%
185,572 $2.58 Million
Q4 2023

Feb 09, 2024

SELL
$13.36 - $15.43 $727,759 - $840,518
-54,473 Reduced 29.76%
128,552 $1.83 Million
Q3 2023

Nov 13, 2023

BUY
$15.03 - $16.32 $680,017 - $738,382
45,244 Added 32.84%
183,025 $2.83 Million
Q2 2023

Aug 11, 2023

BUY
$15.57 - $17.11 $1.88 Million - $2.07 Million
120,782 Added 710.52%
137,781 $2.16 Million
Q1 2023

May 12, 2023

BUY
$15.28 - $16.48 $57,223 - $61,717
3,745 Added 28.26%
16,999 $280,000
Q4 2022

Feb 10, 2023

SELL
$12.42 - $15.62 $4,657 - $5,857
-375 Reduced 2.75%
13,254 $206,000
Q3 2022

Nov 14, 2022

BUY
$12.8 - $28.65 $45,721 - $102,337
3,572 Added 35.52%
13,629 $177,000
Q2 2022

Aug 11, 2022

SELL
$13.12 - $15.03 $376,006 - $430,744
-28,659 Reduced 74.02%
10,057 $142,000
Q1 2022

May 13, 2022

SELL
$13.54 - $15.35 $37,099 - $42,059
-2,740 Reduced 6.61%
38,716 $554,000
Q4 2021

Feb 11, 2022

SELL
$13.17 - $16.4 $566,059 - $704,888
-42,981 Reduced 50.9%
41,456 $565,000
Q3 2021

Nov 12, 2021

SELL
$16.3 - $17.26 $2.84 Million - $3.01 Million
-174,525 Reduced 67.39%
84,437 $1.38 Million
Q2 2021

Aug 13, 2021

SELL
$16.55 - $18.64 $1.93 Million - $2.17 Million
-116,572 Reduced 31.04%
258,962 $4.36 Million
Q1 2021

May 13, 2021

BUY
$16.71 - $19.9 $882,906 - $1.05 Million
52,837 Added 16.37%
375,534 $6.86 Million
Q4 2020

Feb 10, 2021

SELL
$15.39 - $18.97 $680,207 - $838,436
-44,198 Reduced 12.05%
322,697 $5.87 Million
Q3 2020

Nov 12, 2020

SELL
$17.1 - $19.19 $979,060 - $1.1 Million
-57,255 Reduced 13.5%
366,895 $6.55 Million
Q2 2020

Aug 13, 2020

SELL
$14.59 - $19.5 $849,240 - $1.14 Million
-58,207 Reduced 12.07%
424,150 $7.4 Million
Q1 2020

May 13, 2020

BUY
$13.02 - $20.31 $783,491 - $1.22 Million
60,176 Added 14.25%
482,357 $7.32 Million
Q4 2019

Feb 12, 2020

SELL
$16.88 - $20.83 $2.75 Million - $3.4 Million
-163,197 Reduced 27.88%
422,181 $8.33 Million
Q3 2019

Nov 14, 2019

SELL
$16.15 - $17.99 $346,449 - $385,921
-21,452 Reduced 3.54%
585,378 $10 Million
Q2 2019

Aug 14, 2019

BUY
$16.58 - $20.49 $2.64 Million - $3.26 Million
159,317 Added 35.6%
606,830 $10.7 Million
Q1 2019

May 14, 2019

BUY
$16.7 - $21.52 $7.47 Million - $9.63 Million
447,513 New
447,513 $9.12 Million

Others Institutions Holding TAK

About TAKEDA PHARMACEUTICAL CO LTD


  • Ticker TAK
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 3,109,050,112
  • Market Cap $41.2B
  • Description
  • Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan, the United States, Europe, Canada, Latin America, Russia, rest of Asia, and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma derived t...
More about TAK
Track This Portfolio

Track Franklin Resources Inc Portfolio

Follow Franklin Resources Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Franklin Resources Inc, based on Form 13F filings with the SEC.

News

Stay updated on Franklin Resources Inc with notifications on news.